1. Home
  2. JUNS vs VVOS Comparison

JUNS vs VVOS Comparison

Compare JUNS & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JUNS
  • VVOS
  • Stock Information
  • Founded
  • JUNS 2015
  • VVOS 2016
  • Country
  • JUNS United States
  • VVOS United States
  • Employees
  • JUNS N/A
  • VVOS N/A
  • Industry
  • JUNS
  • VVOS Medical Specialities
  • Sector
  • JUNS
  • VVOS Health Care
  • Exchange
  • JUNS NYSE
  • VVOS Nasdaq
  • Market Cap
  • JUNS 17.6M
  • VVOS 18.5M
  • IPO Year
  • JUNS 2024
  • VVOS 2020
  • Fundamental
  • Price
  • JUNS $0.62
  • VVOS $2.10
  • Analyst Decision
  • JUNS
  • VVOS Strong Buy
  • Analyst Count
  • JUNS 0
  • VVOS 2
  • Target Price
  • JUNS N/A
  • VVOS $6.10
  • AVG Volume (30 Days)
  • JUNS 146.8K
  • VVOS 94.7K
  • Earning Date
  • JUNS 05-11-2025
  • VVOS 05-13-2025
  • Dividend Yield
  • JUNS N/A
  • VVOS N/A
  • EPS Growth
  • JUNS N/A
  • VVOS N/A
  • EPS
  • JUNS N/A
  • VVOS N/A
  • Revenue
  • JUNS N/A
  • VVOS $15,031,000.00
  • Revenue This Year
  • JUNS N/A
  • VVOS $23.17
  • Revenue Next Year
  • JUNS N/A
  • VVOS $25.23
  • P/E Ratio
  • JUNS N/A
  • VVOS N/A
  • Revenue Growth
  • JUNS N/A
  • VVOS 8.91
  • 52 Week Low
  • JUNS $0.51
  • VVOS $1.91
  • 52 Week High
  • JUNS $19.51
  • VVOS $6.28
  • Technical
  • Relative Strength Index (RSI)
  • JUNS N/A
  • VVOS 29.04
  • Support Level
  • JUNS N/A
  • VVOS $2.00
  • Resistance Level
  • JUNS N/A
  • VVOS $2.33
  • Average True Range (ATR)
  • JUNS 0.00
  • VVOS 0.29
  • MACD
  • JUNS 0.00
  • VVOS -0.03
  • Stochastic Oscillator
  • JUNS 0.00
  • VVOS 10.08

About JUNS JUPITER NEUROSCIENCES INC

Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: